Labcyte has announced that The Institute of Cancer Research (ICR) has implemented its Access workstation to automate the production of low-volume, assay-ready microplates from high-throughput screening and fragment libraries for biochemical, cell-based, and biophysical screening.
Cancer Research Technology (CRT), the cancer-focused technology development and commercialization arm of Cancer Research UK, announced today the implementation of the Labcyte Access workstation to automate the production of assay-ready plates to be used in a high-throughput cell based screening program.
The Echo® liquid handler that leverages the company’s core acoustic technology is set to revolutionize liquid handling.
Labcyte has patented and released a novel software algorithm that enables a greater range of fluid types to be automatically transferred with acoustic energy. Dynamic Fluid Analysis enables the Echo® liquid handling systems to adapt to fluid properties changes such as surface tension and viscosity, and adjusts sound energy in real time with no operator intervention required. The advanced capabi...
Labcyte Inc., the developer of acoustic liquid handling, and QIAGEN, the leading global provider of sample and assay technologies, announced today that QIAGEN FlexiPlate siRNA reagent libraries are now available in Labcyte Echo® qualified microplates. These microplates enable researchers to use the Echo® liquid handler to miniaturize the transfer of small interfering RNA reagents.